Biohaven completes $264.5M public offering of common shares at $41.00 per share

Biohaven Ltd.

Issued and sold 6,451,220 common shares at $41.00/share, including full exercise of underwriters' option.
Gross proceeds of approximately $264.5 million before underwriting discounts and offering expenses.
Underwriting agreement with J.P. Morgan Securities LLC as representative of several underwriters.
Offering made under effective shelf registration statement filed October 2, 2023 (File No. 333-274822).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.